330 related articles for article (PubMed ID: 33919036)
1. ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer.
Escudero L; Martínez-Ricarte F; Seoane J
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919036
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.
Escudero L; Martínez-Ricarte F; Seoane J
Curr Opin Neurol; 2020 Dec; 33(6):736-741. PubMed ID: 33177377
[TBL] [Abstract][Full Text] [Related]
3. Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors.
Yan W; Xu T; Zhu H; Yu J
Onco Targets Ther; 2020; 13():719-731. PubMed ID: 32158224
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies.
Shah M; Takayasu T; Zorofchian Moghadamtousi S; Arevalo O; Chen M; Lan C; Duose D; Hu P; Zhu JJ; Roy-Chowdhuri S; Riascos RF; Chen H; Luthra R; Esquenazi Y; Ballester LY
J Mol Diagn; 2021 Feb; 23(2):171-180. PubMed ID: 33531134
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications of cerebrospinal fluid liquid biopsies in central nervous system tumors.
Diaz M; Chudsky S; Pentsova E; Miller AM
Transl Oncol; 2024 Mar; 41():101881. PubMed ID: 38218027
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.
Escudero L; Llort A; Arias A; Diaz-Navarro A; Martínez-Ricarte F; Rubio-Perez C; Mayor R; Caratù G; Martínez-Sáez E; Vázquez-Méndez É; Lesende-Rodríguez I; Hladun R; Gros L; Ramón Y Cajal S; Poca MA; Puente XS; Sahuquillo J; Gallego S; Seoane J
Nat Commun; 2020 Oct; 11(1):5376. PubMed ID: 33110059
[TBL] [Abstract][Full Text] [Related]
7. Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors.
Miller AM; Karajannis MA
J Natl Compr Canc Netw; 2022 Dec; 20(12):1363-1369. PubMed ID: 36509077
[TBL] [Abstract][Full Text] [Related]
8. Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases.
Siravegna G; Geuna E; Mussolin B; Crisafulli G; Bartolini A; Galizia D; Casorzo L; Sarotto I; Scaltriti M; Sapino A; Bardelli A; Montemurro F
ESMO Open; 2017; 2(4):e000253. PubMed ID: 29067216
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.
De Mattos-Arruda L; Mayor R; Ng CKY; Weigelt B; Martínez-Ricarte F; Torrejon D; Oliveira M; Arias A; Raventos C; Tang J; Guerini-Rocco E; Martínez-Sáez E; Lois S; Marín O; de la Cruz X; Piscuoglio S; Towers R; Vivancos A; Peg V; Ramon y Cajal S; Carles J; Rodon J; González-Cao M; Tabernero J; Felip E; Sahuquillo J; Berger MF; Cortes J; Reis-Filho JS; Seoane J
Nat Commun; 2015 Nov; 6():8839. PubMed ID: 26554728
[TBL] [Abstract][Full Text] [Related]
10. Detection of the
Zorofchian S; Lu G; Zhu JJ; Duose DY; Windham J; Esquenazi Y; Ballester LY
Front Oncol; 2018; 8():382. PubMed ID: 30294590
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.
Seoane J; De Mattos-Arruda L; Le Rhun E; Bardelli A; Weller M
Ann Oncol; 2019 Feb; 30(2):211-218. PubMed ID: 30576421
[TBL] [Abstract][Full Text] [Related]
12. Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas.
Bobillo S; Crespo M; Escudero L; Mayor R; Raheja P; Carpio C; Rubio-Perez C; Tazón-Vega B; Palacio C; Carabia J; Jiménez I; Nieto JC; Montoro J; Martínez-Ricarte F; Castellvi J; Simó M; Puigdefàbregas L; Abrisqueta P; Bosch F; Seoane J
Haematologica; 2021 Feb; 106(2):513-521. PubMed ID: 32079701
[TBL] [Abstract][Full Text] [Related]
13. Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma.
Friedman JS; Hertz CAJ; Karajannis MA; Miller AM
Neurooncol Adv; 2022 Nov; 4(Suppl 2):ii33-ii40. PubMed ID: 36380863
[TBL] [Abstract][Full Text] [Related]
14. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].
Haupts A; Roth W; Hartmann N
Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
16. Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.
De Mattos-Arruda L; Caldas C
Mol Oncol; 2016 Mar; 10(3):464-74. PubMed ID: 26776681
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications.
Hickman RA; Miller AM; Arcila ME
Transl Oncol; 2023 Jul; 33():101688. PubMed ID: 37196447
[TBL] [Abstract][Full Text] [Related]
18. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
Nevel KS; Wilcox JA; Robell LJ; Umemura Y
Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
[TBL] [Abstract][Full Text] [Related]
19. CSF-ctDNA SMSEQ Analysis to Tailor the Treatment of a Patient with Brain Metastases: A Case Report.
Huang WT; Lu NM; Hsu WY; Chang SE; Atkins A; Mei R; Javey M
Case Rep Oncol; 2018; 11(1):68-74. PubMed ID: 29515413
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
